Oncology
1 drug is in development for Extensive-stage Small-cell Lung Cancer.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Extensive-stage Small-cell Lung Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Zepzelca | Jazz Pharmaceuticals plc (JAZZ) |
About this indication
Extensive-stage Small-cell Lung Cancer context
Oncology·MeSH: Small Cell Lung Carcinoma (D055752)
Narrower concept of MeSH descriptor Small-cell Lung Cancer
Frequently asked questions
How many drugs are in development for Extensive-stage Small-cell Lung Cancer?
BioSniper tracks 1 drug in development for Extensive-stage Small-cell Lung Cancer across 1 company.
How many clinical trials target Extensive-stage Small-cell Lung Cancer?
There are 8 clinical trials targeting Extensive-stage Small-cell Lung Cancer tracked by BioSniper.